Pain News and Research

Latest Pain News and Research

Study: Patients with glaucoma experience psychological problems

Fear of the unknown is one of the greatest issues facing patients with glaucoma - the second leading cause of blindness worldwide after cataracts - according to research in the April issue of the Journal of Advanced Nursing. People also worry about how the eye disease, which can be hereditary, will affect other members of their family.

11 Apr 2011

New experimental drug can help treat peripheral neuropathy in cancer patients

Although oncologists have made great strides in many aspects of cancer treatment, one area that has remained very difficult to treat is peripheral neuropathy, namely pain that can be caused by the cancer or by its treatment.

11 Apr 2011

Researchers discover new avenue for hypertension, cardiovascular disease treatment

More than one-third of the world's population suffers from hypertension and cardiovascular disease. The U.S. Agency for Healthcare Quality and Research has reported that Americans spent $29 billion for non-prescription cardiovascular drugs alone in 2008.

11 Apr 2011

Annals of Neurology publishes Diamyd Medical´s NP2 Enkephalin Phase I results in cancer pain

Diamyd Medical´s Phase I clinical trial results evaluating the safety and efficacy of the candidate drug NP2 Enkephalin to treat intractable cancer pain has been published in the medical journal Annals of Neurology.

11 Apr 2011

Florida Society of Pain Management Providers applauds Senate President for supporting PDMP

The Florida Society of Pain Management Providers, applauds Senate President Mike Haridopolos, Senator Mike Fasano and Attorney General Pam Bondi for their support of the Prescription Drug Monitoring Program and their united opposition to the attempt to repeal the program.

11 Apr 2011

New dengue test receives FDA marketing clearance

The U.S. Food and Drug Administration today allowed marketing of the first test to help diagnose people with signs and symptoms of dengue fever or dengue hemorrhagic fever, a leading cause of illness and death in the tropics and subtropics.

11 Apr 2011

Novation adds St. Jude Medical to portfolio of Cardiac Rhythm Management products

Novation, the leading health care supply contracting company, announced today the addition of St. Jude Medical (St. Paul, MN) to its portfolio of agreements for Cardiac Rhythm Management products.

8 Apr 2011

Hope4Cancer offers gentle non-invasive therapies for patients with brain tumor

Linda Roberts was puzzled when her favorite food, chocolate ice cream, suddenly did not taste good, and her prized orchids didn't smell nice either. When she began having sudden, severe headaches, she mentioned the changes in taste and smell to her doctor. After several tests, Roberts was diagnosed with a glioblastoma multiforme, the most aggressive form of brain tumor.

8 Apr 2011

Meditation can conquer pain: Well almost!

Meditation can be used as a powerful painkiller says new research published in the Journal of Neuroscience. The study from Wake Forest Baptist Medical Center showed as much reflected in perception of the participants as well as their brain scans.

7 Apr 2011

MAP Pharma publishes LEVADEX Phase 3 FREEDOM-301 study data in 'Headache' journal

MAP Pharmaceuticals, Inc. today announced the publication of results from the Phase 3 FREEDOM-301 study of LEVADEX orally inhaled migraine drug in the peer-reviewed journal 'Headache.'

7 Apr 2011

OncoGenex, Teva's custirsen preclinical data in CRPC presented at AACR meeting

Teva Pharmaceutical Industries Ltd. and OncoGenex Pharmaceuticals, Inc. announced today that new preclinical data of their investigational compound custirsen in castrate resistant prostate cancer were presented this week at the 102nd Annual Meeting of the AACR.

7 Apr 2011

Breast cancer survivors with poor physical health scores at elevated risk of poorer outcomes

Breast cancer survivors with poor physical health scores had an elevated risk of poorer cancer outcomes, including recurrence and death, according to the results of an observational study presented at the AACR 102nd Annual Meeting 2011, held April 2-6.

7 Apr 2011

Positive results from Neuros Medical Electrical Nerve Block technology study in chronic pain

Neuros Medical, Inc., a medical device company, announced promising results today from their recently completed feasibility study. The study was the first human test of the Company's patented high frequency Electrical Nerve Block™ technology and focused on patients with chronic amputation pain which affects nearly one million patients in the U.S. During the study, four of the five patients reported their pain was reduced to zero.

7 Apr 2011

AstraZeneca receives FDA approval for vandetanib to treat medullary thyroid cancer

The U.S. Food and Drug Administration today approved vandetanib to treat adult patients with late-stage (metastatic) medullary thyroid cancer who are ineligible for surgery and who have disease that is growing or causing symptoms.

7 Apr 2011

Chemical senses scientists to hold 33rd annual meeting, April 13-17, 2011

The Association for Chemoreception Sciences (AChemS), a US-based scientific organization, is holding its 33rd annual meeting. About 700 scientists are gathering to present new information on the role of smell and taste in disease, nutrition, and social interactions in humans as well as animals. Smell and taste play essential roles in our daily lives.

6 Apr 2011

Novartis' TOBI Podhaler receives Health Canada NOC for Pa treatment in CF patients

Novartis Canada announced today that it has received Health Canada Notice of Compliance for TOBI Podhaler, a fast and convenient inhaled therapy for cystic fibrosis patients aged six and over.

6 Apr 2011

Comprehensive book on chronic pain and addiction

Up to date and comprehensive, this book is relevant to all professionals engaged in the care of patients with chronic pain or addiction and all others interested in these contemporary issues, particularly non-clinicians seeking clarity in the controversy over the best approach to patients with chronic pain.

6 Apr 2011

Study finds marked increases in teen use of marijuana and Ecstasy

Following a decade of steady declines, a new national study released today by The Partnership at Drugfree.org and MetLife Foundation indicates that teen drug and alcohol use is headed in the wrong direction, with marked increases in teen use of marijuana and Ecstasy over the past three years.

6 Apr 2011

Higher prescribed doses associated with increased risk of opioid overdose death

In an analysis of opioid prescription patterns and deaths, receiving higher prescribed doses is associated with an increased risk of opioid overdose death, but receiving both as-needed and regularly scheduled doses is not associated with overdose risk, according to a study in the April 6 issue of JAMA.

6 Apr 2011

Teenagers with scoliosis can benefit from new generation spine implants

Teenagers who undergo spine fusion for scoliosis using the newest surgical techniques can expect to be doing well 10 years after surgery, according to a Hospital for Special Surgery study published online ahead of print in the TK issue of the journal Spine.

6 Apr 2011

Pain News and Research

Latest Pain News and Research

Study: Patients with glaucoma experience psychological problems

New experimental drug can help treat peripheral neuropathy in cancer patients

Researchers discover new avenue for hypertension, cardiovascular disease treatment

Annals of Neurology publishes Diamyd Medical´s NP2 Enkephalin Phase I results in cancer pain

Florida Society of Pain Management Providers applauds Senate President for supporting PDMP

New dengue test receives FDA marketing clearance

Novation adds St. Jude Medical to portfolio of Cardiac Rhythm Management products

Hope4Cancer offers gentle non-invasive therapies for patients with brain tumor

Meditation can conquer pain: Well almost!

MAP Pharma publishes LEVADEX Phase 3 FREEDOM-301 study data in 'Headache' journal

OncoGenex, Teva's custirsen preclinical data in CRPC presented at AACR meeting

Breast cancer survivors with poor physical health scores at elevated risk of poorer outcomes

Positive results from Neuros Medical Electrical Nerve Block technology study in chronic pain

AstraZeneca receives FDA approval for vandetanib to treat medullary thyroid cancer

Chemical senses scientists to hold 33rd annual meeting, April 13-17, 2011

Novartis' TOBI Podhaler receives Health Canada NOC for Pa treatment in CF patients

Comprehensive book on chronic pain and addiction

Study finds marked increases in teen use of marijuana and Ecstasy

Higher prescribed doses associated with increased risk of opioid overdose death

Teenagers with scoliosis can benefit from new generation spine implants

Exploring the nanoscale: How AFM is transforming cosmetic science

Innovating Texture and Culture in Plant-Based Foods

Advancing brain microphysiological systems (bMPS)

Pain News and Research

Latest Pain News and Research

Exploring the nanoscale: How AFM is transforming cosmetic science

Innovating Texture and Culture in Plant-Based Foods

Advancing brain microphysiological systems (bMPS)

Newsletters you may be interested in